CHAMPIONS ONCOLOGY, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.00% for the 12-month period ending 2019-04-30, per its 10-K filed 2019-07-29.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2019-07-29
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2019 was 0.00%.
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2018 was 0.00%.
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2017 was -0.30%.
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2016 was -2.20%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2019-04-30 | 0.00% 10-K · filed 2019-07-29 | |
| 2018-04-30 | 0.00% 10-K · filed 2019-07-29 | 2.50% 10-K · filed 2018-07-30 |
| 2017-04-30 | -0.30% 10-K · filed 2018-07-30 | |
| 2016-04-30 | -2.20% 10-K · filed 2017-07-28 | |
| 2015-04-30 | -6.90% 10-K · filed 2016-07-29 | |
| 2014-04-30 | -2.10% 10-K · filed 2015-07-29 | |
| 2013-04-30 | 1.60% 10-K · filed 2014-07-28 | |
| 2012-04-30 | -3.00% 10-K · filed 2013-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |